Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Endometrial Neoplasms × Observation × Clear all

Phase

Phase 3 3 Phase 2 2 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Endometrial Neoplasms 1

Interventions

Medroxyprogesterone Acetate 2 pazopanib 1 palbociclib 1 olaparib 1 lenvatinib 1 fluciclovine F-18 1 dostarlimab 1 Watchful Waiting 1 Sunitinib 1 Specimen Handling 1 Observation 1 Metformin 1 LY 353381 1 Indocyanine Green 1 High-Energy Shock Waves 1 Biomarkers 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡